Company Search:
Advanced Search
Sponsored Links
Novacyt Sa Company Snapshot
Novacyt Sa operates in the Electromedical equipment sector. In addition to historical fundamental analyses, the complete report available to purchase compares Novacyt Sa with three other companies in this sector in France: Alpha Mos (2016 sales of 7.47 million Euro [US$8.86 million] ), Mauna Kea Technologies SAS (8.79 million Euro [US$10.42 million] of which 48% was Equipment), and Theradiag Sa (8.98 million Euro [US$10.65 million] ).

Sales Analysis. Novacyt Sa reported sales of 11.08 million Euro (US$13.14 million) for the year ending December of 2016. This represents an increase of 24.6% versus 2015, when the company's sales were 8.89 million Euro. Sales at Novacyt Sa have increased during each of the previous five years (and since 2011, sales have increased a total of 4,724%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Novacyt Sa
  Stock Performance Chart for Novacyt Sa
  Stock Data: Recent Stock Performance:
  Current Price (10/13/2017): .83
(Figures in Euro)
1 Week 2.5%   13 Weeks -1.2%  
4 Weeks -5.7%   52 Weeks -34.6%  
Novacyt Sa Key Data:
  Ticker: ALNOV Country: France
  Exchanges: PAR Major Industry: Health Care Equipment & Services
    Sub Industry: Electromedical Equipment
  2016 Sales 11,076,000
(Year Ending Jan 2017).
Employees: 6
  Currency: Euro Market Cap: 18,332,407
  Fiscal Yr Ends: December Shares Outstanding: 22,087,237
  Share Type: Ordinary Closely Held Shares: 4,261,897
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.